Claret Medical Announces First Patient Treated in U.S. Pivotal Trial Evaluating Cerebral Protection During ...

Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart, vascular and cardiac surgery procedures, today announced that the first patient has been successfully treated in its SENTINEL Trial in the United States, a multicenter pivotal trial of the Sentinel™ Cerebral Protection System .



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1q2ClIE

via IFTTT